U.S. Markets closed
  • S&P 500

    4,704.54
    +15.87 (+0.34%)
     
  • Dow 30

    35,870.95
    -60.10 (-0.17%)
     
  • Nasdaq

    15,993.71
    +72.14 (+0.45%)
     
  • Russell 2000

    2,363.59
    -13.42 (-0.56%)
     
  • Gold

    1,861.20
    -0.20 (-0.01%)
     
  • Silver

    24.88
    -0.02 (-0.08%)
     
  • EUR/USD

    1.1369
    -0.0006 (-0.0568%)
     
  • 10-Yr Bond

    1.5890
    -0.0150 (-0.94%)
     
  • Vix

    17.59
    +0.48 (+2.81%)
     
  • GBP/USD

    1.3497
    -0.0003 (-0.0216%)
     
  • USD/JPY

    114.3040
    +0.0520 (+0.0455%)
     
  • BTC-USD

    56,458.66
    +1,623.64 (+2.96%)
     
  • CMC Crypto 200

    1,402.14
    -65.80 (-4.48%)
     
  • FTSE 100

    7,255.96
    -35.24 (-0.48%)
     
  • Nikkei 225

    29,683.09
    +84.43 (+0.29%)
     

28 Stocks Moving In Monday's Mid-Day Session

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Gainers

  • Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical studies. Northland Capital Markets upgraded the stock from Market Perform to Outperform.

  • Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) gained 74% to $8.04. Supernus Pharmaceuticals agreed to acquire Adamas Pharmaceuticals for $9.10 per share, or $450 million.

  • Flexion Therapeutics, Inc. (NASDAQ: FLXN) gained 60.9% to $9.30. Pacira BioSciences agreed to acquire Flexion Therapeutics for $8.50 per share in cash, plus one contingent value right (CVR) worth up to $8.00 per share in cash.

  • U.S. Well Services, Inc. (NASDAQ: USWS) jumped 29.6% to $3.1099 in sympathy with the price of oil amid increased demand and limited supply.

  • EZFill Holdings Inc. (NASDAQ: EZFL) surged 17% to $4.0790 after the company announced it has purchased 33 additional fuel trucks, more than tripling the size of its delivery fleet.

  • Blue Apron Holdings, Inc. (NYSE: APRN) gained 16.2% to $7.95.

  • Gaotu Techedu Inc. (NASDAQ: GOTU) rose 16% to $3.9250.

  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) surged 15% to $11.21. Traders circulated Oct. 7 FDA approval for the company’s Dextenza.

  • Katapult Holdings, Inc. (NASDAQ: KPLT) rose 13.2% to $5.18. Katapult Holdings became an Accelerate partner in the Adobe Exchange Program.

  • DatChat, Inc. (NASDAQ: DATS) gained 13% to $13.24.

  • TETRA Technologies, Inc. (NYSE: TTI) rose 12.8% to $3.86 in sympathy with the price of oil amid increased demand and limited supply.

  • Innoviz Technologies Ltd. (NASDAQ: INVZ) gained 12.3% to $5.22.

  • Willamette Valley Vineyards, Inc. (NASDAQ: WVVI) surged 11.3% to $14.25.

  • Nutriband Inc. (NASDAQ: NTRB) shares gained 10.5% to $7.40 after dropping over 14% on Friday.

  • Trevi Therapeutics, Inc. (NASDAQ: TRVI) gained 10% to $1.33 after the company filed Friday to withdraw its offering of shares.

  • Matinas BioPharma Holdings, Inc. (NASDAQ: MTNB) rose 8.5% to $1.1501.

  • Liquidia Corporation (NASDAQ: LQDA) rose 7.9% to $7.40 after the company received favorable ruling in Inter Partes Review against United Therapeutics patent.

  • AIkido Pharma Inc. (NASDAQ: AIKI) shares rose 6.8% to $0.9289. HC Wainwright & Co. initiated coverage on AIkido Pharma with a Buy rating and announced a price target of $2.

Check out these big penny stock gainers and losers

Losers

  • Cipher Mining Inc. (NASDAQ: CIFR) shares dropped 18.8% to $6.41.

  • AeroCentury Corp. (NYSE: ACY) shares fell 14% to $52.44.

  • SecureWorks Corp. (NASDAQ: SCWX) shares declined 13.3% to $20.13.

  • Voyager Therapeutics, Inc. (NASDAQ: VYGR) dropped 11.3% to $4.92 after jumping around 45% on Friday.

  • PagSeguro Digital Ltd. (NASDAQ: PAGS) fell 11.1% to $32.51 after dropping 19% on Friday.

  • MeaTech 3D Ltd. (NASDAQ: MITC) dropped 10.3% to $7.62. Meatech 3D recently said it is partnering with a collective led by Ashton Kutcher and Guy Oseary, together with strategic players like Effie Epstein, to accelerate growth in developing, commercializing cultured meat production technologies.

  • eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) fell 9.7% to $10.69. eFFECTOR Therapeutics, in collaboration with Baylor College of Medicine, recently announced the presentation of new positive data for zotatifin in animal models of triple-negative breast cancer (TNBC).

  • Hyliion Holdings Corp. (NYSE: HYLN) dropped 9% to $7.11 after UBS downgraded the stock from Neutral to Sell and lowered its price target from $14 to $5.

  • BEST Inc. (NYSE: BEST) fell 8.2% to $1.8997.

  • Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) dropped 7.5% to $9.56.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.